Talis Biomedical Corp Annual Return On Equity in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Talis Biomedical Corp quarterly/annual Return On Equity history and growth rate from 2020 to 2023.
  • Talis Biomedical Corp Return On Equity for the quarter ending June 30, 2024 was -79.7 %, a 12.8% decline year-over-year.
  • Talis Biomedical Corp annual Return On Equity for 2023 was -69.5 %, a 1.28% decline from 2022.
  • Talis Biomedical Corp annual Return On Equity for 2022 was -68.6 %, a 2.07% decline from 2021.
  • Talis Biomedical Corp annual Return On Equity for 2021 was -67.2 %, a 144% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -69.5 -0.88 -1.28% Jan 1, 2023 Dec 31, 2023
2022 -68.6 -1.39 -2.07% Jan 1, 2022 Dec 31, 2022
2021 -67.2 -219 -144% Jan 1, 2021 Dec 31, 2021
2020 152 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.